Daily news on science and technology in Virginia

Provided by AGP

Virginia STEM News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Virginia STEM News.

Press releases published on March 2, 2026

Digital Realty Enters Bulgaria with Acquisition of Highly Connected Interconnection Hub in Sofia
GT Biopharma Reports Full Year 2025 Financial Results
ADMA Biologics Announces $125 Million Accelerated Share Repurchase with JPMorgan as Part of a Planned $200 Million 2026 Total Share Repurchase Initiative
NRx Pharmaceuticals (Nasdaq: NRXP) Appoints Prof. Joshua Brown MD, PhD, as Chief Medical Innovation Officer
Agios’ PYRUKYND® (mitapivat) Approved for Adults with Thalassemia in the United Arab Emirates
uniQure Provides Regulatory Update on AMT-130 for Huntington’s Disease
Fueled by U.S. Success, GEEK BAR Launches SPARK to Lead a New Era in Europe
Kaspi.kz 4Q & FY 2025 Financial Results
SPARC AI Appoints Matt McCrann as U.S. CEO
Xanadu and Crane Harbor Announce SEC Declaration of Effectiveness of Form F-4 Registration Statement
25% of Americans expect streaming discounts for binge-watching shows
Deucrictibant Data Supporting Potentially Differentiated Profile for the On-Demand and Prophylactic Treatment of Bradykinin-Mediated Angioedema Presented at AAAAI 2026
Stovex Global Deepens Strategic Cooperation, Investing $5 Million in Dedicated Funds to Support Casder Vanguard AI 5.0 Live Testing and System Upgrades
Virtune fügt dem Virtune Coinbase 50 Index ETP fünf neue Kryptowerte hinzu und erweitert den Index-ETP damit auf insgesamt 26 Vermögenswerte
Virtune adds five new crypto assets to the Virtune Coinbase 50 Index ETP, expanding the index ETP to a total of 26 assets
Virtune inkluderar fem nya kryptotillgångar i Virtune Coinbase 50 Index ETP och utökar därmed index-ETP:n till totalt 26 tillgångar
Alaunos Therapeutics Announces Positive Preclinical Proof-of-Concept Data for ALN1003, a Differentiated Non-Hormonal Oral Treatment for Obesity and Related Metabolic Disorders
Zymeworks and Royalty Pharma Enter into $250 Million Royalty-Backed Note Financing
Zymeworks Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results
Belite Bio Reports Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Results and Provides a Corporate Update

Share us

on your social networks:

Sign up for:

Virginia STEM News

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.